Mirum Pharmaceuticals

Mike Grey, chairman and CEO
Mike Grey, chairman and CEO
USA | Funding: $497M (+)

Website: https://mirumpharma.com/

Mirum Pharmaceuticals develops drugs for rare cholestatic liver diseases.